http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102011004987-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ddcb273a108a5d8472b335280098e06
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0009
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N11-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5138
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y5-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82B3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82B1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04
filingDate 2011-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a53b36a0aad2851fb86f40ecbebaaef3
publicationDate 2011-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-102011004987-A1
titleOfInvention Magnetic nanoparticles and group of nanoparticles
abstract For a particularly effective stem cell therapy, a nanoparticle comprising a first element consisting of a magnetic material, a carrier or sheath element consisting of a biodegradable material, a first substance containing an X-ray contrast medium, and a second substance containing stem cells is provided, wherein the stem cells are designed to be useful for angiogenesis or myogenesis.
priorityDate 2010-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009234220-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5843780-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452927767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24414
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14945

Total number of triples: 38.